History of Acrodermatitis Enteropathica

  • Pooya Khan Mohammad Beigi
  • Emanual Maverakis


Acrodermatitis Enteropathica (AE) is an inherited autosomal recessive disorder which often presents in newborn infants [1]. This medical condition occurs as a result of mutation of a zinc transporter that affects the uptake of zinc in the intestine causing a decrease in the level of this elemental mineral in the blood [2]. Prior to this knowledge, untreated AE was considered deleterious to the infant’s health and sometimes even fatal [3, 4]. Today however, the treatment involves adding zinc supplements to the patient’s diet which can easily improve the condition [1, 3].


Zinc Deficiency Serum Zinc Autosomal Recessive Disorder Zinc Transporter Serum Zinc Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Maverakis E, et al. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol. 2007;56(1):116–24.PubMedCrossRefGoogle Scholar
  2. 2.
    Puri N. A study of efficacy of oral zinc therapy for acrodermatitis enteropathica. Nasza dermatolologia online. 2013;4:162–6.CrossRefGoogle Scholar
  3. 3.
    Van Wouwe JP. Clinical and laboratory diagnosis of acrodermatitis enteropathica. Eur J Pediatr. 1989;149(1):2–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Aggett PJ. Acrodermatitis enteropathica. J Inherit Metab Dis. 1983;6 Suppl 1:39–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Wende GW. Epidermolysis bullosa hereditaria. J Cut Dis. 1902;20:537–47.Google Scholar
  6. 6.
    Brandt T. Dermatitis in children with disturbances of the general condition and the absorption of food elements. Acta Derm. 1936;17:513–46.Google Scholar
  7. 7.
    Danbolt N, Closs K. Acrodermatitis enteropathica. Acta Derm Venerol. 1942;23:127–69.Google Scholar
  8. 8.
    Neldner KH, Hambidge KM. Zinc therapy of acrodermatitis enteropathica. N Engl J Med. 1975;292(17):879–82.PubMedCrossRefGoogle Scholar
  9. 9.
    Moynahan EJ. Letter: acrodermatitis enteropathica: a lethal inherited human zinc-deficiency disorder. Lancet. 1974;2(7877):399–400.PubMedCrossRefGoogle Scholar
  10. 10.
    Aggett PJ, et al. The therapeutic effect of amphotericin in acrodermatitis enteropathica: hypothesis and implications. Eur J Pediatr. 1981;137(1):23–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Hurley LS, et al. Zinc-binding ligands in milk and intestine: a role in neonatal nutrition? Proc Natl Acad Sci U S A. 1977;74(8):3547–9.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Evans GW, Johnson PE. Characterization and quantitation of a zinc-binding ligand in human milk. Pediatr Res. 1980;14(7):876–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Küry S, et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet. 2002;31(3):239–40.PubMedCrossRefGoogle Scholar
  14. 14.
    Wang K, et al. Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3. Am J Hum Genet. 2001;68(4):1055–60.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Pooya Khan Mohammad Beigi
    • 1
    • 2
  • Emanual Maverakis
    • 3
  1. 1.University of British ColumbiaVancouverCanada
  2. 2.New York Medical CollegeValhallaUSA
  3. 3.University of California DavisSacramentoUSA

Personalised recommendations